Genotyping in urine: An interesting tool for epidemiological studies

Clinical Chemistry

Volumn 44, Issue 10, 1998, Pages 2210-2211

  Haufroid, Vincent ^a   Clippe, André ^a   Knoops, Bernard ^a   Bernard, Alfred ^a   Lison, Dominique ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYLNITROSAMINE DEMETHYLASE; DNA;

ARTICLE; BLOOD SAMPLING; GENOTYPE; HUMAN; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; URINALYSIS;

EID: 0031697364     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/44.10.2210     Document Type: Article

References (5)

1. Puga A, Nebert DW, McKinnon RA, Menon AG. Genetic polymorphisms in human drug-metabolizing enzymes: potential uses of reverse genetics to identify genes of toxicological relevance. Crit Rev Toxicol 1997;27:199-222.
2. Rannug A, Alexandrie AK, Persson I, Ingelman-Sundberg M. Genetic polymorphism of cytochromes P450 1A1, 2D6 and 2E1: regulation and toxicological significance. J Occup Environ Med 1995;37:25-36.
3. Watanabe J, Hayashi SI, Nakachi K, Imai K, Suda Y, Sekine T, Kawajiri K. PstI and RsaI RFLPs in complete linkage disequilibrium at the CVP2E gene. Nucleic Acids Res 1990;18:7194.
4. Uematsu F, Kikuchi H, Ohmachi T, Sagami I, Motomiya M, Kamataki T, et al. Two common RFLPs of the human CYP2E gene. Nucleic Acids Res 1991; 19:2803.
5. McBride OW, Umeno M, Gelboin HV, Gonzalez FJ. A. TaqI polymorphism in the human P450IIE1 gene on chromosome 10 (CYP2E). Nucleic Acids Res 1987;15:10071.